In one paragraphArticle in Nature aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Lutz MenzelEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. lmenzel1@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-3816-6255 Meghan J O'MeliaEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Pin-Ji LeiEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Lingshan LiuEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Hang LeeBiostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Lance L MunnEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Lena JonassonDepartment of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Timothy P PaderaEdwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. tpadera@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-3453-9384 Funding
Systems biology of lymphatic transportR01HL128168 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MUNN, LANCE L., PADERA, TIMOTHY P · 2015 to 2019
$2.9MTargeting lymph node metastases to prevent cancer progressionR01CA214913 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI PADERA, TIMOTHY P · 2017 to 2022
$2.0MTargeting lymph node metastases to block cancer progressionR01CA284372 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI TIMOTHY P PADERA · 2023 to 2026
$2.0MSystems Biology of Antigen and T-Cell Transport in Cancer ImmunotherapyR01CA284603 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Lance L. Munn, TIMOTHY P PADERA · 2023 to 2026
$1.9MReversing aging-induced lymphatic dysfunction to improve immune functionR21AG072205 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI PADERA, TIMOTHY P · 2022 to 2023
$458kA mechanistic dissection of the role of Eya3 in breast cancer metastasisK00CA234940 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI ZHOU, HENGBO · 2020 to 2023
$405kEnhanced antigen-lymphocyte interactions to improve immune checkpoint blockade in breast cancerF32CA275298 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI O'MELIA, MEGHAN · 2022 to 2024
$213kDeutsche Forschungsgemeinschaft (German Research Foundation) ME 5486/1-2Deutsche Forschungsgemeinschaft (German Research Foundation) ME 5486/2-1Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) DP2 AI176139Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) U19 AI082630Hjärt-Lungfonden (Swedish Heart-Lung Foundation) 20180436U.S. Department of Health & Human Services | National Institutes of Health (NIH) F32CA275298U.S. Department of Health & Human Services | National Institutes of Health (NIH) K00CA234940U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01CA214913U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01CA284372U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01CA284603U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HL128168U.S. Department of Health & Human Services | National Institutes of Health (NIH) R21AG072205Vetenskapsrådet (Swedish Research Council) 2018-03232
6 · The paper itselfAbstract
The abundance of diverse naive CD8
What Socratic holds
Textmetadata
Read underepoch 390